Methylene blue for lithium-induced refractory hypotension in off-pump coronary artery bypass graft: report of two cases  by Sparicio, Donatella et al.
3. Raz I, Okon E, Cheajek-Shaul E. Pulmonary manifestation of Behc¸et’s
disease. Chest. 1989;95:585-9.
4. Bang DS, Lee JH, Lee ES, et al. Epidermiologic and clinical survey of
Behc¸et’s disease in Korea: the first multicenter study. J Korean Med Sci.
2001;16:L615-8.
5. Erkan F. Pulmonary involvement in Behc¸et’s disease. Curr Opin Pulm
Med. 1999;5:314-8.
6. Okita Y, Ando M, Minatoya K, et al. Pseudoaneurysm of aortic arch,
right subclavian artery and abdominal aorta in a patient with Behc¸et’s
disease. J Vasc Surg. 1998;28:723-6.
7. Nonaka K, Makuuchi H, Naruse J, et al. Pseudoaneurysm of aortic arch
and rupture into pericardium, a case report of successful surgical man-
agement. Jpn J Thorac Cardiovasc Surg. 1998;46:772-6.
8. Tunaci A, Berkmen YM, Gokmen E. Thoracic involvement in Behc¸et’s
disease: pathologic, clinical, and imaging features. Am J Roentgenol.
1995;164:51-6.
Methylene blue for lithium-induced refractory hypotension in off-pump
coronary artery bypass graft: Report of two cases
Donatella Sparicio, MD, Giovanni Landoni, MD, Federico Pappalardo, MD, Martina Crivellari, MD, Elisa Cerchierini, MD,
Giovanni Marino, MD, and Alberto Zangrillo, MD, Milano, Italy
Off-pump surgery is gaining popularity for coronaryartery bypass grafting (CABG). We report the peri-operative management of 2 patients who self-assumedlithium and had refractory hypotension during beating
heart surgery. Both patients had a dramatic hemodynamic im-
provement after receiving methylene blue.
Clinical Summary
Two men (57 and 68 years, each weighing 72 kg, height 180 and
186 cm) with coronary artery disease and ejection fraction greater
than 50% were scheduled for elective off-pump CABG. Medical
history included depression on treatment with benzodiazepines and
lithium carbonate (300 mg every 8 hours). They were both on
treatment with beta-blockers (atenolol and carvedilol), calcium
antagonist (amlodipine), nitrates, and aspirin; patient A also used
an angiotensin-converting enzyme inhibitor. Both patients had an
unnoticed self-administration of lithium the morning before sur-
gery.
Standard premedication and anesthesia were administered. Tar-
get coronary vessels were mechanically stabilized and posterior
vessel presentation obtained with a suspension stitch placed in the
middle of the 4 pulmonary veins. Both patients received an in situ
internal thoracic artery graft to the left anterior descending artery
and a saphenous vein graft to the posterior descending and obtuse
marginal arteries. Hypotension ensued after pericardial opening
and anastomosis. Arterial blood pressure, 80/50 mm Hg (mean
arterial pressure  60 mm Hg), was not responsive to etilephrine
boluses, atrial pacing, dopamine infusion (10 g/kg/min), steep
Trendelenburg position, fluid loading, and opening of both pleura;
nevertheless, patients’ stability, in the absence of arrhythmias or
ST-T changes, maintenance of diuresis, and an optimal coopera-
tion between anesthesiologist and surgeon, permitted concluding
the procedure without converting to cardiopulmonary bypass. In-
traoperative transesophageal echocardiography demonstrated nor-
mal biventricular function without new segmental acinesia. In the
hypothesis of vasoplegia both patients received methylene blue
(1.5 mg/kg intravenously) in 20 minutes with a rapid improvement
of mean arterial pressure (80 mm Hg).
At the end of the operation, the patients were transferred to the
intensive care unit and had an uneventful postoperative course.
Discussion
Lithium (Li), the primary drug used for the treatment of bipolar
(maniac-depressive) disorders, may induce prolonged sleep time
after barbiturate anesthesia, enhanced neuromuscular blockade
after muscle relaxant administration, and cardiac conduction ab-
normalities.1 The mechanism of action of Li as a mood-stabiliz-
ing agent remains unknown. Therapeutic doses of lithium interfere
with the metabolism of cathecolamines that are involved in the
pathophysiology of the troubles of humor; Li also inhibits the
liberation of norepinephrine and dopamine from the nervous ter-
minations, strengthens the liberation of serotonin, and increases
the presynaptic reuptake and storage of catecholamines. Further-
more, it has interactions with drugs like angiotensin-converting
enzyme inhibitors (which reduce Li clearance with possible Li
toxicity) and beta-blockers (which enhance the central depression
induced by lithium).
In light of these pharmacodynamic properties, in these patients
we suspected that chronic lithium therapy played a role in the
unresponsiveness to vasoconstrictor agents. Lithium should be
discontinued before surgery, at least the day of the operation,
especially when high blood pressures are requested during sur-
gery.2
Methylene blue inhibits the enzyme guanylate cyclase, avoid-
ing the cyclic guanosine 3'5'-monophosphate-dependent vasore-
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laxant effects of nitric oxide in the smooth muscle of vessels. It has
been used as an unconventional drug to treat refractory vasoplegia
after cardiopulmonary bypass, anaphylaxis, and septic shock.3-5
We especially appreciated its use in these patients because the
alternative drug (norepineprine), in the postoperative period of
cardiac surgery, could be detrimental, especially after CABG. No
data exist on the effects of methylene blue on arterial conduits.
Conclusion
We recommend lithium to be discontinued before surgery and
suggest methylene blue as an alternative drug to treat vasodilatory
shock in the perioperative period of cardiac surgery.
We are in debt to Gherbi Giordano, RN, for the care provided
to these patients.
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Pathologic findings of aortic redissection
after glue repair of proximal aorta
Masao Yoshitatsu, MD,a Fumikazu Nomura, MD,a Akira Katayama,
MD,a Kentaro Tamura, MD,a Keijiro Katayama, MD,a Katsuhiko Ihara,
MD,a and Yutaka Nakashima, MD, PhD,b Hiroshima and Fukuoka,
Japan
Gelatin-resorcinol-formaldehyde (GRF) glue (Cardial,Technopole, Sainte-Etienne, France) has become thestandard choice in the repair of type A dissections.1Several authors have reported the incidence of redis-
section of the aortic wall just proximal to the anastomosis. The
causes remain controversial and some investigators reported that
redissection might be caused by necrosis of the aortic wall caused
by GRF glue.2-4 We present our clinical experience with redissec-
tion of the aortic root late after repair of type A aortic dissection.
Clinical Summary
A 62-year-old male patient had total aortic arch replacement
because of aortic dissection (Stanford type A) in December 1999.
The distal lumen was fixed with GRF glue and the proximal aortic
stump was reinforced with a 1-cm glued Xenomedica strip (Baxter
Healthcare Co, Deerfield, Ill) outside and 0.5 cm of 2-mm poly-
tetrafluoroethylene sheet (Gore-Tex; W. L. Gore & Associates,
Inc, Flagstaff, Ariz) inside with mattress sutures from inside to
outside, and a 28-mm straight Hemashield graft (Meadox Medi-
cals, Oakland, NJ) was anastomosed. The patient’s hospital course
was unremarkable, without any complications, and he was dis-
charged from the hospital 5 weeks after the operation.
During the 3 years after operation, contrast-enhanced chest
computed tomographic (CT) scans were performed once or twice
a year and redissection was not detected. Heart murmur was not
audible. As the CT scan on March 2002 revealed redissection of
the aortic root, reoperation was considered. At this time diastolic
murmur was audible and echocardiography showed moderate aor-
tic regurgitation. Only 2 months later echocardiography demon-
strated that aortic regurgitation was becoming severe.
The patient underwent aortic root replacement on July 2002.
The proximal aortic wall seemed necrotic at the site where GRF
glue had been used previously. The intimal layer from the left
coronary to right coronary (posterior side) was disrupted from
the anastomotic site, which caused the formation of a pseudo-
From the Division of Cardiovascular Surgery, National Kure Medical
Center,a Hiroshima, Japan, and Department of Pathophysiological and
Experimental Pathology, Graduate School of Medical Sciences, Kyushu
University,b Fukuoka, Japan.
Received for publication Aug 18, 2003; accepted for publication Sept 15,
2003.
Address for reprints: Masao Yoshitatsu, Division of Cardiovascular Sur-
gery, National Kure Medical Center, 3-1, Aoyama, Kure, Hiroshima 737-
0023, Japan (E-mail: yoshitatsu@kure-nh.go.jp).
J Thorac Cardiovasc Surg 2004;127:593-5
0022-5223/$30.00
Copyright © 2004 by The American Association for Thoracic Surgery
doi:10.1016/j.jtcvs.2003.09.021
Brief Communications
The Journal of Thoracic and Cardiovascular Surgery ● Volume 127, Number 2 593
